Search

Sophia S. Chen

Examiner (ID: 4164, Phone: (571)272-2133 , Office: P/2852 )

Most Active Art Unit
2852
Art Unit(s)
2809, 2105, 2852
Total Applications
3623
Issued Applications
3447
Pending Applications
91
Abandoned Applications
111

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8779607 [patent_doc_number] => 20130101582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'Tiki1 and Tiki2, Wnt Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/715443 [patent_app_country] => US [patent_app_date] => 2012-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23958 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13715443 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/715443
Tiki1 and Tiki2, Wnt Inhibitors Dec 13, 2012 Abandoned
Array ( [id] => 9174964 [patent_doc_number] => 20130316949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members' [patent_app_type] => utility [patent_app_number] => 13/707717 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13066 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13707717 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/707717
Compositions and Methods for Minimally-Invasive Systemic Delivery of Proteins Including TGF-Beta Superfamily Members Dec 6, 2012 Abandoned
Array ( [id] => 8768024 [patent_doc_number] => 20130096061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'METHOD OF TREATING SKELETAL DYSPLASIAS USING VESSEL DILATOR' [patent_app_type] => utility [patent_app_number] => 13/693372 [patent_app_country] => US [patent_app_date] => 2012-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7448 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13693372 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/693372
METHOD OF TREATING SKELETAL DYSPLASIAS USING VESSEL DILATOR Dec 3, 2012 Abandoned
Array ( [id] => 9122044 [patent_doc_number] => 20130288966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease' [patent_app_type] => utility [patent_app_number] => 13/680381 [patent_app_country] => US [patent_app_date] => 2012-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14439 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680381 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/680381
Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease Nov 18, 2012 Abandoned
Array ( [id] => 8815142 [patent_doc_number] => 20130116187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'ARTIFICIAL CARTILAGE AND ITS PRODUCTION METHOD' [patent_app_type] => utility [patent_app_number] => 13/670738 [patent_app_country] => US [patent_app_date] => 2012-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4991 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13670738 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/670738
ARTIFICIAL CARTILAGE AND ITS PRODUCTION METHOD Nov 6, 2012 Abandoned
Array ( [id] => 8950080 [patent_doc_number] => 20130195860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'Antibody targeting through a modular recognition domain' [patent_app_type] => utility [patent_app_number] => 13/694155 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12877 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13694155 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/694155
Antibody targeting through a modular recognition domain Oct 31, 2012 Abandoned
Array ( [id] => 9183432 [patent_doc_number] => 08623364 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Antigenic GM-CSF peptides and antibodies to GM-CSF' [patent_app_type] => utility [patent_app_number] => 13/659165 [patent_app_country] => US [patent_app_date] => 2012-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 27511 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13659165 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/659165
Antigenic GM-CSF peptides and antibodies to GM-CSF Oct 23, 2012 Issued
Array ( [id] => 10926231 [patent_doc_number] => 20140329252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS' [patent_app_type] => utility [patent_app_number] => 14/351398 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 19837 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14351398 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/351398
METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS Oct 14, 2012 Abandoned
Array ( [id] => 9936880 [patent_doc_number] => 08986685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Compositions and methods for increasing bone mineralization' [patent_app_type] => utility [patent_app_number] => 13/644728 [patent_app_country] => US [patent_app_date] => 2012-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 27729 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13644728 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/644728
Compositions and methods for increasing bone mineralization Oct 3, 2012 Issued
Array ( [id] => 9383438 [patent_doc_number] => 20140086919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'METHODS AND COMPOSITONS FOR REGULATING IRON HOMEOSTASIS BY MODULATION OF BMP-6' [patent_app_type] => utility [patent_app_number] => 13/625049 [patent_app_country] => US [patent_app_date] => 2012-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18701 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13625049 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/625049
METHODS AND COMPOSITONS FOR REGULATING IRON HOMEOSTASIS BY MODULATION OF BMP-6 Sep 23, 2012 Abandoned
Array ( [id] => 10354937 [patent_doc_number] => 20150239942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'USE OF PEDF-DERIVED POLYPEPTIDES FOR TREATING OSTEOARTHRITIS' [patent_app_type] => utility [patent_app_number] => 14/429693 [patent_app_country] => US [patent_app_date] => 2012-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8166 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429693 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/429693
Use of PEDF-derived polypeptides for treating osteoarthritis Sep 19, 2012 Issued
Array ( [id] => 12037659 [patent_doc_number] => 09815878 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-14 [patent_title] => 'Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging' [patent_app_type] => utility [patent_app_number] => 14/429681 [patent_app_country] => US [patent_app_date] => 2012-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10357 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14429681 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/429681
Use of PEDF-derived polypeptides for preventing and/or ameliorating skin aging Sep 18, 2012 Issued
Array ( [id] => 8606134 [patent_doc_number] => 20130011446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'CERAMIC COMPOSITION FOR FILLING BONE DEFECTS' [patent_app_type] => utility [patent_app_number] => 13/614369 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4597 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13614369 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/614369
CERAMIC COMPOSITION FOR FILLING BONE DEFECTS Sep 12, 2012 Abandoned
Array ( [id] => 9016320 [patent_doc_number] => 20130231284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'METHODS OF TREATING CARTILAGE DEFECTS' [patent_app_type] => utility [patent_app_number] => 13/612251 [patent_app_country] => US [patent_app_date] => 2012-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18873 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13612251 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/612251
METHODS OF TREATING CARTILAGE DEFECTS Sep 11, 2012 Abandoned
Array ( [id] => 9254433 [patent_doc_number] => 08617844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Use of cytokine receptors as biomarkers and therapeutic targets in human cancer' [patent_app_type] => utility [patent_app_number] => 13/595436 [patent_app_country] => US [patent_app_date] => 2012-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5009 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13595436 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/595436
Use of cytokine receptors as biomarkers and therapeutic targets in human cancer Aug 26, 2012 Issued
Array ( [id] => 10654718 [patent_doc_number] => 20160000862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'USE OF PEDF-DERIVED POLYPEPTIDES FOR PROMOTING MUSCLE OR TENDON REGENERATION OR ARTERIOGENESIS' [patent_app_type] => utility [patent_app_number] => 14/420581 [patent_app_country] => US [patent_app_date] => 2012-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14581 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14420581 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/420581
Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis Aug 8, 2012 Issued
Array ( [id] => 8950059 [patent_doc_number] => 20130195838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases' [patent_app_type] => utility [patent_app_number] => 13/571283 [patent_app_country] => US [patent_app_date] => 2012-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 82611 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13571283 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/571283
Methods of Treating Cancer Using Growth Factor Retargeted Endopeptidases Aug 8, 2012 Abandoned
Array ( [id] => 15395879 [patent_doc_number] => 10538584 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-21 [patent_title] => Methods for treating bone gap defects [patent_app_type] => utility [patent_app_number] => 14/233137 [patent_app_country] => US [patent_app_date] => 2012-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 6 [patent_no_of_words] => 16478 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233137 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/233137
Methods for treating bone gap defects Aug 1, 2012 Issued
Array ( [id] => 8495390 [patent_doc_number] => 20120294798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'METHODS OF TREATING CANCER USING IL-21' [patent_app_type] => utility [patent_app_number] => 13/535832 [patent_app_country] => US [patent_app_date] => 2012-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49624 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535832 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/535832
METHODS OF TREATING CANCER USING IL-21 Jun 27, 2012 Abandoned
Array ( [id] => 9263144 [patent_doc_number] => 20130345073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'USE OF ALPHA-2-MACROGLOBULIN FOR DETERMINING OSTEONECROSIS DISEASE STATUS AND FOR SCREENING THERAPEUTIC AGENTS FOR PREVENTING OR TREATING OSTEONECROSIS' [patent_app_type] => utility [patent_app_number] => 13/530342 [patent_app_country] => US [patent_app_date] => 2012-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26877 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13530342 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/530342
USE OF ALPHA-2-MACROGLOBULIN FOR DETERMINING OSTEONECROSIS DISEASE STATUS AND FOR SCREENING THERAPEUTIC AGENTS FOR PREVENTING OR TREATING OSTEONECROSIS Jun 21, 2012 Abandoned
Menu